Author: siric.montpellier@icm.unicancer.fr

[vc_row][vc_column][vc_column_text] In 2023 ESMO TAT will be dedicated to improving the conduct of early anti-cancer clinical trials, bringing together those who are developing the most promising new cancer drugs and unveiling exciting new data. Stakeholders from academia and industry will discuss with clinicians, researchers, and regulators the global dissemination of knowledge and clinical research expertise

Tuesday, January 31, 2022, 11:00 am, IGMM conference room “Bcl2 family members in colorectal cancer” Prof. Jan Paul Medema, Cancer Center, Amsterdam Jan Paul’s group made major contributions in the field of colorectal cancer. Some of their recent publications: Di Franco, S., Bianca, P., Sardina, D.S., Turdo, A., Gaggianesi, M., Veschi, V., Nicotra, A., Mangiapane, L.R.,

[vc_row][vc_column][vc_column_text] The MAD4Cancer Symposium meeting  will be held at IRCM, Montpellier February 2-3rd. The meeting is organized in the context of the application for the MAD4CANCER ERASMUS+ Master prepared by the Universities of Pavia, Montreal and Montpellier. The purpose is to bring together researchers of the three universities to stimulate potential collaborations, especially in the context of the internships of the future Master’s